Acquisition Insight Kinray was acquired by Cardinal Health for $1.3B in 2010, indicating a strong exit history and potential for relationship resumption with a large successor in the pharmaceutical distribution ecosystem.
Mid-Sized Scale With 51-200 employees and revenue in the $100M–$250M range, Kinray sits in a middle market segment that often seeks cost efficiencies, technology enhancements, and value-added services from a corporate supplier.
Tech Stack Signals Current technologies include DreamWeaver and Google Analytics, suggesting opportunities to propose modern content management, analytics-driven marketing, or digital transformation initiatives to optimize customer acquisition and product visibility.
Alignment with Big Given As a former independent entity now under Cardinal Health lineage, Kinray may be open to collaborations that leverage Cardinal Health’ distribution network, scale economies, and integrated supply chain capabilities.
Market Positioning Kinray operates in pharmaceutical manufacturing with peers like McKesson, Cardinal Health, and AmerisourceBergen; this hints at potential cross-sell, partnerships, or services that differentiate through efficiency, compliance, or specialty capabilities.